Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chhanda J Kapadia

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drug Development and Industrial Pharmacy|December 22, 2007
Raft-forming agents: antireflux formulationsChhanda J Kapadia, Vidya B Mane
Current Drug Delivery|May 8, 2009
Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tabletsAgnivesh R Shrivastava, Bhalchandra Ursekar, Chhanda J Kapadia
Indian Journal of Pharmaceutical Sciences|January 23, 2016
Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol(®) 888ATO as Lipid ExcipientShilpa N Patere, Chhanda J Kapadia, Mangal S Nagarsenker
Current Drug Delivery|April 24, 2013
Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC studyShilpa N Patere, Neha S Desai, Ankitkumar S Jain, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drug Development and Industrial Pharmacy|December 22, 2007
Raft-forming agents: antireflux formulationsChhanda J Kapadia, Vidya B Mane
Current Drug Delivery|May 8, 2009
Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tabletsAgnivesh R Shrivastava, Bhalchandra Ursekar, Chhanda J Kapadia
Indian Journal of Pharmaceutical Sciences|January 23, 2016
Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol(®) 888ATO as Lipid ExcipientShilpa N Patere, Chhanda J Kapadia, Mangal S Nagarsenker
Current Drug Delivery|April 24, 2013
Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC studyShilpa N Patere, Neha S Desai, Ankitkumar S Jain, et al.
Pageof 1